Live Breaking News & Updates on Clinical Study Protocol

Stay updated with breaking news from Clinical study protocol. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

MEI Pharma Reports Initial Data from Clinical Study Evaluating ME-344 in Combination with Bevacizumab (Avastin®) in Relapsed Metastatic Colorectal Cancer Patients

MEI Pharma Reports Initial Data from Clinical Study Evaluating ME-344 in Combination with Bevacizumab (Avastin®) in Relapsed Metastatic Colorectal Cancer Patients
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

David Urso , Richard Ghalie , Pharma Inc , Academic Gi Cancer Consortium , Clinical Study Protocol , Bevacizumab Combination , Initial Safety , Initial Efficacy ,

MEI Pharma (MEIP) Reports Initial Data from Study of ME-344 in Combination with Bevacizumab

MEI Pharma (MEIP) Reports Initial Data from Study of ME-344 in Combination with Bevacizumab
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Davida Walsey , David Urso , Richard Ghalie , Mei Pharma Inc , Pharma Inc , Academic Gi Cancer Consortium , Clinical Study Protocol , Bevacizumab Combination , Initial Safety , Initial Efficacy , Private Securities Litigation Reform Act ,

PharmAust kick-starts MND trial with lead drug and reports positive signs in canine cancer trials

Clinical stage biotechnology company PharmAust's (ASX: PAA) September quarter was highlighted by the commencement of its Motor Neurone Disease (MND) trial, recruiting its first four patients, as additional patients undergo screening to become the next-in-line. ....

Western Australia , United States , New Zealand , Anusha Aubert , Fiona Milner , Ergomed Clinical Research , Motor Neurone Disease , Clinical Study Protocol , Principal Investigator ,